Anti-Serpin-B2 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the amino-terminal region of mature human Serpin-B2, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Pan, Monkey
UniProt
P05120
Size
100ug
Cat. #
RP2SerpinB2

In stock

SKU
RP-SerpinB2

Options

As low as: $130.00

Target Overview

Serpin-B2, also known as plasminogen activator inhibitor-2 (PAI-2) or urokinase inhibitor, is a member of the clade B serine protease inhibitor (serpin) superfamily encoded by the SERPINB2 gene (UniProt P05120). Unlike the structurally related PAI-1, which is primarily secreted by endothelial cells, Serpin-B2 is predominantly cytoplasmic and expressed by monocytes, macrophages, and placental tissue. The protein comprises 415 amino acids and functions as a selective inhibitor of urokinase-type plasminogen activator (uPA), a key regulator of extracellular proteolysis and fibrinolysis. Serpin-B2 is distinct from endothelial-derived PAI-1 in both cellular origin and regulatory context. Expression is often induced during inflammation, pregnancy, and certain malignancies. Its cytoplasmic localization and lack of a classical signal peptide distinguish it from most other plasminogen activator inhibitors, though secreted glycosylated forms have been reported under specific conditions. Researchers study Serpin-B2 in the context of fibrinolytic balance, immune cell function, tumor invasion, and tissue remodeling.

Background

Serpin-B2 plays a central role in controlling urokinase-mediated plasminogen activation, thereby modulating fibrinolysis, cell migration, and extracellular matrix degradation. While PAI-1 is the dominant circulatory inhibitor of tissue-type plasminogen activator (tPA) and uPA, Serpin-B2 functions primarily in the intracellular compartment and in localized extracellular microenvironments. Its expression is tightly regulated and increases in response to inflammatory cytokines, differentiation signals in myeloid cells, and during pregnancy in placental tissues. The distinct monocyte-derived Arg-serpin isoform underscores its specialized role in innate immunity and inflammation. Recent work has implicated Serpin-B2 in diverse pathological contexts. Zhu et al (2026) demonstrated that epithelial overexpression of SERPINB2 in chronic rhinosinusitis with nasal polyps contributes to impaired fibrinolysis through downregulation of tPA, suggesting a role in mucosal remodeling disorders. Bhat et al (2026) identified SERPINB2 among gene expression signatures associated with vaso-occlusive episodes in sickle cell disease, highlighting potential involvement in microvascular pathology. Chen et al (2026) integrated machine learning and colocalization analyses to nominate SERPINB2 as a candidate biomarker in Crohn's disease, linking serpin dysregulation to intestinal inflammation. The dual nature of Serpin-B2 as both an intracellular regulator and, under certain conditions, a secreted factor complicates its study. Investigators examining uPA-dependent processes, fibrinolytic imbalance, or monocyte/macrophage biology frequently require detection of endogenous Serpin-B2 by Western blot in human tissues and cell lysates. Two rabbit polyclonal antibodies targeting the amino-terminal region of mature PAI-2 are available from Triple Point Biologics, validated for Western blot with predicted cross-reactivity in non-human primates.

References

  1. Zhu Y et al (2026) Epithelial SERPINB2 Overexpression Contributes to Impaired Fibrinolysis in Chronic Rhinosinusitis With Nasal Polyps via tPA Downregulation. Front Biosci (Landmark Ed). PubMed · 10.31083/FBL50406
  2. Bhat V et al (2026) Gene expression profiling identifies potential biomarkers for vaso-occlusive episodes in sickle cell disease. JCI Insight. PubMed · 10.1172/jci.insight.193359
  3. Chen L (2026) Identification of Novel Biomarkers for Crohn's Disease Through the Integration of Machine Learning, Colocalization, and SMR Analysis. FASEB J. PubMed · 10.1096/fj.202504792R

Additional Specifications

Gene Symbol SerpinB2
UniProt ID P05120
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Pan, Monkey
Pack Size 100ug
Immunogen (Amino end mature PAI-2)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-51.
Immunogen (Reactive Center Loop (RCL))Immunogen is proprietary and confidential. Immunogen generated in amino acid region 370-410.
Alternate Names PAI-2, Plasminogen activator inhibitor 2, Plasminogen activator inhibitor-2, Monocyte Arg-serpin, Placental plasminogen activator inhibitor, Serpin B2, SERPINB2, Urokinase inhibitor

Frequently Asked Questions

What molecular weight should I expect for Serpin-B2 on a Western blot?

Serpin-B2 (PAI-2) migrates at approximately 47 kDa on SDS-PAGE under reducing conditions, corresponding to its 415-amino-acid sequence. You may observe a glycosylated form near 60 kDa if working with secreted Serpin-B2, though the predominant cytoplasmic isoform is non-glycosylated. Some cell types express both forms simultaneously. If you see a doublet or higher-molecular-weight species, confirm your sample source and consider whether your cells are stimulated or transformed, as glycosylation increases during differentiation or inflammatory activation.

Is this Serpin-B2 antibody suitable for detecting PAI-2 in monocyte or macrophage lysates?

Yes. Serpin-B2 is expressed at high levels in monocytes and macrophages, particularly upon LPS or cytokine stimulation. We recommend starting at 1:1000 dilution for Western blot of whole-cell lysates from THP-1, U937, or primary human monocytes. Basal expression can be low in unstimulated cells; consider treating with LPS, TNF-α, or PMA for 6 to 24 hours to induce robust Serpin-B2 signal. Placental tissue serves as a strong positive control.

Can I use this antibody to distinguish Serpin-B2 from PAI-1 in the same sample?

Yes. Despite functional overlap, Serpin-B2 and PAI-1 (Serpin-E1) are distinct gene products with no significant sequence homology outside the serpin domain. This polyclonal was raised against a Serpin-B2-specific epitope and does not cross-react with PAI-1 in our validation panels. On Western blot, PAI-1 migrates near 45 to 50 kDa, overlapping with non-glycosylated Serpin-B2, so molecular weight alone will not resolve them. Use isoform-specific antibodies or verify by siRNA knockdown if both serpins are abundant in your system.

What starting dilution should I use for immunohistochemistry on formalin-fixed tissue?

We recommend a starting dilution of 1:200 to 1:500 for IHC on FFPE sections, with citrate-based antigen retrieval at pH 6.0. Serpin-B2 staining is typically cytoplasmic in monocytes, macrophages, and syncytiotrophoblasts. For frozen sections, 1:500 to 1:1000 often works well. Titre empirically against your tissue type; expression is inducible and heterogeneous. Positive-control tissues include term placenta and inflamed colon or synovium. Normal liver and kidney are generally negative or very weakly positive.

Will this antibody detect Serpin-B2 in mouse or rat samples?

Cross-reactivity with rodent Serpin-B2 is predicted based on sequence homology but not formally validated. Human and mouse SERPINB2 share approximately 60 percent identity at the amino-acid level. If you are working with mouse models, we suggest testing at the recommended 1:1000 dilution and including a positive control such as LPS-stimulated mouse peritoneal macrophages. Monkey (non-human primate) reactivity is more likely given higher sequence conservation, but empirical validation remains advisable.

How should I prepare cell lysates to preserve Serpin-B2 signal for Western blot?

Serpin-B2 is a cytoplasmic protein and readily extracted in standard RIPA or NP-40 lysis buffers supplemented with protease inhibitors. Avoid prolonged incubation at room temperature; serpins can undergo conformational changes or proteolysis. Snap-freeze pellets or lyse on ice, then clarify at 4 degrees Celsius. Load 20 to 40 micrograms total protein per lane for most adherent cell lines; you may need more for weakly expressing primary cells. Boil samples in reducing Laemmli buffer for five minutes before loading.

What are recommended positive and negative control cell lines for Serpin-B2 expression?

THP-1 or U937 human monocytic leukemia cells, especially after PMA or LPS treatment, serve as robust positive controls. HT-1080 fibrosarcoma cells also express Serpin-B2 constitutively. For negative controls, HEK293T and NIH-3T3 typically show minimal or undetectable expression under basal conditions. Primary human keratinocytes and some epithelial lines express Serpin-B2 variably depending on passage and differentiation state. Placental villous tissue remains the gold-standard positive control for method development.

How stable is this antibody during repeated freeze-thaw cycles and what storage is recommended?

Store the antibody at minus 20 degrees Celsius as supplied. For routine use, aliquot upon receipt to minimize freeze-thaw cycles; rabbit polyclonal antibodies generally tolerate two to three cycles without major titre loss, but repeated thawing accelerates aggregation and can reduce signal. For long-term storage beyond one year, keep at minus 80 degrees Celsius. Avoid storing diluted antibody; prepare working dilutions fresh in blocking buffer on the day of use to maintain consistent performance across experiments.

Western blot validation for RP-SerpinB2 — 1 panel across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Serpin-B2: Amino end mature PAI-2 — WB validation
WB · Panel 1 Serpin-B2: Amino end mature PAI-2

Custom validation studies available on request — contact us.

Also known as:

  • PAI-2
  • Plasminogen activator inhibitor 2
  • Plasminogen activator inhibitor-2
  • Monocyte Arg-serpin
  • Placental plasminogen activator inhibitor
  • Serpin B2
  • SERPINB2
  • Urokinase inhibitor
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →